首页> 外文期刊>European Journal of Pharmacology: An International Journal >Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways
【24h】

Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways

机译:雌激素相关受体α的下调抑制人皮肤鳞状细胞癌细胞增殖,通过纤连蛋白和Stat3信号传导途径调节EMT

获取原文
获取原文并翻译 | 示例
           

摘要

Estrogen-related receptor alpha (ERR alpha), one of orphan nuclear receptors, has been recently revealed as an oncogenic regulator in a variety of cancers. However, the linking gain of ERR alpha expression and cancer progression in cutaneous squamous cell carcinoma (cSCC) is largely unknown. Here, we showed that the mRNA and protein expression levels of ERR alpha were markedly higher in A431 cells compared with human keratinocyte cell line HaCaT, and targeted inhibition of ERR alpha by shRNA or its inverse agonist XCT790 significantly suppressed A431 cells proliferation and migration, while overexpression of ERR alpha promoted cell proliferation and migration. In addition, the data revealed that ERR alpha downregulation markedly inhibited the epithelial mesenchymal transition (EMT) of A431 cells with increasing the expression of E-cadherin and decreasing fibronectin (FN) and vimentin. Results from further experiments using Western blot suggested that ERR alpha suppression inhibited signal transducer and activator of transcription (STAT3) protein expression. In contrast, overexpression of ERR alpha promoted EMT and the activation of STAT3 pathway. Moreover, treatment with specific STAT3 inhibitor reversed EMT markers in ERR alpha-overexpressing A431 cells. In tumor xenografts of A431 cells, we further showed that ERR alpha depletion inhibited cSCC tumor growth in vivo. Taken together, these results demonstrate, for the first time, that ERR alpha may function as an oncoprotein in cSCC to accelerate tumor aggressiveness by promoting EMT via FN and STAT3 pathway, and it could be a novel target for cSCC therapy.
机译:最近透露了雌激素相关的受体α(ERRα),孤儿核受体之一,作为各种癌症的致癌稳压剂。然而,在皮肤鳞状细胞癌(CSCC)中,ERRα表达和癌症进展的连接增益在很大程度上是未知的。在这里,我们认为,与人角蛋白细胞细胞系HaCAT相比,ERα的mRNA和蛋白表达水平在A431细胞中明显高,并且通过ShRNA或其反向激动剂XCT790的靶向抑制抑制α231细胞增殖和迁移显着抑制了A431细胞增殖和迁移ERRα过度表达促进细胞增殖和迁移。此外,数据显示,ERα下调显着抑制A431细胞的上皮间充质转换(EMT)随着E-Cadherin的表达和纤维连接蛋白(Fn)和Vimentin的表达。使用Western印迹的进一步实验结果表明,ERRα抑制抑制信号传感器和转录激活剂(STAT3)蛋白表达。相反,ERRα的过度表达促进了EMT和STAT3途径的激活。此外,用特定的STAT3抑制剂治疗在错误α-过度抑制A431细胞中反转EMT标记。在A431细胞的肿瘤异种移植物中,我们进一步表明ERRα耗竭抑制了体内CSCC肿瘤生长。总之,这些结果首次证明ERRα可以用作CSCC中的癌蛋白,通过通过FN和Stat3途径促进EMT来加速肿瘤侵袭性,并且它可能是CSCC治疗的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号